Progesterone sustained release (Catalent/Dare Bioscience)

N/A

Report date: 2024/05/09 17:32:52

Base Information

Drug NameProgesterone sustained release (Catalent/Dare Bioscience)

Drug Alias NameProgesterone intravaginal (Catalent/Dare Bioscience)Estrogen/progesterone intravaginal (Catalent/Dare Bioscience)DARE-PTB1JNP 0301DARE-FRT1

ClassificationSmall molecules > Steroids

Mechanisms of ActionProgesterone receptor agonists

TargetsProgesterone receptor

Therapy Area/IndicationsVasomotor symptomVulvar and vaginal atrophyObstetric Labor, Premature

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesJuniper Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesDaré Bioscience Inc

Inactive CompaniesN/A

Active IndicationsVasomotor symptomVulvar and vaginal atrophyObstetric Labor, Premature

Inactive IndicationsN/A

Other Information

ATC CodeN/A